Kristiansen J E, Justesen T, Hvidberg E F, Andersen L P
Department of Clinical Microbiology, Central Hospital, Hillerød, Denmark.
Pharmacol Toxicol. 1989 Apr;64(4):386-8. doi: 10.1111/j.1600-0773.1989.tb00672.x.
A series of conventional anti-ulcer drugs, tricyclic antidepressants and neuroleptics (and some CNS non-active isomers) were tested in vitro for possible inhibition of Campylobacter pylori. These bacteria are claimed to play an etiological role in peptic ulcer disease, at least in gastritis B. While cimetidine, famotidine, ranitidine and pirenzepine were inactive, all the antipsychotic agents and their isomeric derivatives were active to various degrees with IC50 of 26-59 microM. Of special interest is trimipramine (Surmontil) that has been demonstrated to be effective against duodenal ulcers in some trials. The activity of the non-neuroleptic stereo-isomers of clopenthixol and chlorprothixene may lead to investigation in patients with peptic ulcer disease of this kind of agents. However, a firm connection between the antimicrobial activity of these compounds, their possible anti-ulcer effect and the etiological role of Campylobacter pylori in peptic ulcer disease must first be established.
对一系列传统抗溃疡药物、三环类抗抑郁药和抗精神病药(以及一些中枢神经系统无活性的异构体)进行了体外测试,以检测其对幽门螺杆菌的潜在抑制作用。据称,这些细菌至少在B型胃炎中在消化性溃疡病的病因学中起作用。虽然西咪替丁、法莫替丁、雷尼替丁和哌仑西平无活性,但所有抗精神病药物及其异构体衍生物均有不同程度的活性,IC50为26 - 59微摩尔。特别值得关注的是曲米帕明(苏明托),在一些试验中已证明其对十二指肠溃疡有效。氯普噻吨和氯丙硫蒽的非抗精神病立体异构体的活性可能会促使对这类药物在消化性溃疡病患者中的研究。然而,必须首先确立这些化合物的抗菌活性、它们可能的抗溃疡作用以及幽门螺杆菌在消化性溃疡病中的病因学作用之间的牢固联系。